M. Divangahi
Associate Professor
DEPARTMENT OF PATHOLOGY
McGill University
Canada
Biography
Dr. Maziar Divangahi completed his PhD in the Department of Medicine at McGill University in 2005. He went to pursue three fellowships in Molecular Immunology and Infectious Diseases at McMaster University, McGill and Harvard University before being appointed at McGill as an Assistant Professor in the departments of Medicine and Microbiology & Immunology. He joined the Department of Pathology as an associate member in 2012.
Research Interest
Dr. Divangahi's research focuses on investigating the cellular and molecular mechanisms involved in cross-talk between innate and adaptive immunity to major pulmonary infectious diseases such as influenza and tuberculosis. He believes that understanding the different arms of immunity are essential for the future development of an effective therapy or vaccine.
Publications
-
Freund's adjuvant, NOD2 and mycobacteria. Behr MA, Divangahi M. Curr Opin Microbiol. 2014 Dec 5;23C:126-132.
-
Toll-like receptor 4 ablation in mdx mice reveals innate immunity as a therapeutic target in Duchenne muscular dystrophy. Giordano C, Mojumdar K, Liang F, Lemaire C, Li T, Richardson J, Divangahi M, Qureshi S, Petrof BJ. Hum Mol Genet. 2014 Dec 30. pii: ddu735.
-
Annexin1 regulates DC efferocytosis and cross-presentation during Mycobacterium tuberculosis infection. Tzelepis F, Verway M, Daoud J, Gillard J, Hassani-Ardakani K, Dunn J, Downey J, Gentile ME, Jaworska J, Sanchez AM, Nédélec Y, Vali H, Tabrizian M, Kristof AS, King IL, Barreiro LB, Divangahi M. J Clin Invest. 2014 Dec 22. pii: 77014.
